Novo Nordisk A/s
Clinical trials sponsored by Novo Nordisk A/s, explained in plain language.
-
Weekly shot shows promise for childhood obesity in major trial
Disease control OngoingThis study tests whether a weekly injection of semaglutide helps children aged 6 to 17 with obesity or overweight lose weight. About 210 kids will receive either the drug or a placebo, plus lifestyle advice. The study lasts about 2.5 years and focuses on safety and long-term weig…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Weekly shot could replace daily injections for short kids
Disease control OngoingThis study tests whether a new once-weekly growth hormone medicine (somapacitan) works as well as the standard daily shot (Norditropin) for children born small who remain short. About 62 children aged 2.5 to 11 years will receive either weekly or daily injections for up to 5 year…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 15, 2026 11:53 UTC